Article Details

Halozyme Announces Roche's OCREVUS® SC with ENHANZE® Receives European ...

Retrieved on: 2024-06-25 06:17:19

Tags for this article:

Click the tags to see associated articles and topics

Halozyme Announces Roche's OCREVUS® SC with ENHANZE® Receives European .... View article details on hiswai:

Excerpt

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Roche received European Commission (EC) marketing authorization of ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up